8-51820457-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052937.4(PCMTD1):āc.968C>Gā(p.Ala323Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000725 in 1,613,758 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00046 ( 0 hom., cov: 33)
Exomes š: 0.000032 ( 1 hom. )
Consequence
PCMTD1
NM_052937.4 missense
NM_052937.4 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 3.78
Genes affected
PCMTD1 (HGNC:30483): (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1) Predicted to enable protein-L-isoaspartate (D-aspartate) O-methyltransferase activity. Predicted to be involved in protein methylation. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.005237192).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCMTD1 | NM_052937.4 | c.968C>G | p.Ala323Gly | missense_variant | 6/6 | ENST00000522514.6 | NP_443169.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCMTD1 | ENST00000522514.6 | c.968C>G | p.Ala323Gly | missense_variant | 6/6 | 2 | NM_052937.4 | ENSP00000428099.1 | ||
PCMTD1 | ENST00000544451.2 | c.740C>G | p.Ala247Gly | missense_variant | 4/4 | 1 | ENSP00000444026.1 | |||
PCMTD1 | ENST00000360540.9 | c.968C>G | p.Ala323Gly | missense_variant | 7/7 | 5 | ENSP00000353739.5 | |||
PCMTD1 | ENST00000519559.1 | n.894C>G | non_coding_transcript_exon_variant | 6/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152132Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
70
AN:
152132
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000996 AC: 25AN: 250892Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135634
GnomAD3 exomes
AF:
AC:
25
AN:
250892
Hom.:
AF XY:
AC XY:
8
AN XY:
135634
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461508Hom.: 1 Cov.: 30 AF XY: 0.0000316 AC XY: 23AN XY: 727038
GnomAD4 exome
AF:
AC:
47
AN:
1461508
Hom.:
Cov.:
30
AF XY:
AC XY:
23
AN XY:
727038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000460 AC: 70AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74454
GnomAD4 genome
AF:
AC:
70
AN:
152250
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
55
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.968C>G (p.A323G) alteration is located in exon 6 (coding exon 5) of the PCMTD1 gene. This alteration results from a C to G substitution at nucleotide position 968, causing the alanine (A) at amino acid position 323 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
.;2.6715660745E-4;.
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at